Compare Enzyme (MLN) vs HumidiFi (WET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs HumidiFi — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while HumidiFi trades at Rp1,233 (market cap Rp278,05M, Rp89,24M 24h volume). The key difference: HumidiFi is far larger — about 2.1× Enzyme's market cap, and HumidiFi's supply is capped (230M / 1B WET (23%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and HumidiFi for 6 Days on average.
| MLN | WET | |
|---|---|---|
Market Cap | Rp134,13M | Rp278,05M |
Volume (24h) | Rp104,56M | Rp89,24M |
Circulating Supply | 3,3M MLN | 230M / 1B WET (23%) |
Typical Hold Time | 28 Days | 6 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
HumidiFi (WET) trades at Rp1,204.3 with neutral technical signals across most indicators. The token shows balanced market sentiment with equal buy/sell/neutral signals. Current price sits near the pivot point of Rp1,206, indicating potential for directional movement. With only 23% of max supply in circulation and relatively low market cap of Rp278.89 million, the token remains in early adoption phase with limited network activity data available.
Overall outlook suggests cautious monitoring as the token lacks significant fundamental developments or major exchange presence. Key opportunity lies in the low market cap potential, while major risks include limited liquidity and the token's early-stage ecosystem development requiring careful risk management for investors.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About HumidiFi
HumidiFi is Solana’s largest decentralized exchange by volume, processing over $1B daily and capturing ~35% of the network’s spot activity. As a “prop AMM”, it blends on-chain execution with institutional market-making logic to offer tighter spreads, deeper liquidity, and stronger execution than typical DEXs and CEXs.
Read more on WET →
